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THE obvious structural and functional interdependence ofnormal tissue stroma
and malignant cells in solid tumours persuaded the earliest radiobiological investi-
gators that the effect of ionising radiation on these composite structures was the
resultant of separate damage to the normal and malignant tissue components. It
is understandable that, with a persistent inability to quantitate separately the
damage to either component, unlimited scope prevailed for the assertion of rival
theories in which the response of a tumour was attributed preferentially to direct
damage to one or other component. Histological study ofirradiated experimental
tumours is of very limited value in assessing the contribution of direct stromal
damage. This follows from the fact that direct damage to blood vessels is not
readily distinguishable from changes consequent on the regression ofstroma which
must be expected to follow the dissolution of tumour cells whose reproductive
integrity has been directly damaged by the irradiation.
Recent developments in the quantitative radiobiology of mammalian tumour
cells irradiated in vivo have encouraged interpretations of tumour response which
refer, often exclusively, to the direct effect of radiation on the clonogenic cell
population of the tumour. Such exclusive consideration has undoubtedly been
proved to be justified in respect of the relation between the estimated size of a
tumour cell population in a tumour and the single dose ofradiation required for its
cure under specified conditions of oxygenation. This relation has been found to
accord with the predictions of relevant radiation survival curves (Hewitt, 1963;
Reinhold and De Bree, 1966), this last information being obtained under conditions
where stromal changes make no contribution. Suit, Shalek and Wette (1964)
conclude from their extensive dose-cure studies of murine adenocarcinoma that
their results " do not indicate a tissue effect on cellular radiosensitivity, tumour
bed effect on tumour curability, or non-specific host-tumour effect ".
If, as it appears, radiation-induced damage to the stroma makes no measurable
contribution to the eradication or " cure " of a tumour, the question remains
whether such damage influences the character of the changes of tumour volume
which are brought about by irradiation of a tumour in vivo. The consideration
achieves particular importance when attempts are made to interpret tumour
regrowth curves in terms of survival curves for the clonogenic tumour cells.
Thomlinson and Craddock (1967) state that, for the rat fibrosarcoma they studied,
the oxygen enhancement ratio determined from measurements of the growth
response oftheir tumours to irradiation is considerably greater than that obtained
from in vitro studies of the clonogenic cells of their tumour. They refer to capil-
lary damage as possibly conducing to the discrepancy. Several reports have
appeared of the volume response of tumours to a single or fractionated dose ofTRANSPLANTED TUMOURS IN PRE-IRRADIATED SITES
radiation in which, following temporary regression, the tumours eventually revert
to exponential growth at the same rate as before irradiation (Suit and Shalek,
1963; Breur, 1966; Hewitt, 1967). Although such full recovery of growth rate is
not always observed (Thomlinson and Craddock, 1967; Hewitt, 1967) it is com-
monly assumed in the treatment of data (e.g. Hawkes, Hill, Lindop, Ellis and
Rotblat, 1968) or in the development of concepts of tumour response.
Full recovery of tumour exponential growth rate following irradiation implies
that radiation damage to the tumour stroma or to the normal tissue surrounding
the tumour, into which it grows, does not result in restraint of growth. This
apparent failure oftumour regrowth to be impaired by radiation damage to tissues
by which it gains access to the constitutional resources of the host, remarkable in
itself, is in conflict with the results of experiments in which tumours are trans-
planted into previously irradiated sites. Such experiments provide a facility for
examining some features of the effect of stromal damage on tumour growth,
although it must be realised that the effects of irradiation on quiescent normal
tissue are unlikely to resemble closely the effects on tissue that has been stimulated
by the demands of an established growing tumour.
A brief historical review by Stenstrom, Vermund, Mosser and AMarvin (1955)
indicates that restraint of transplanted tumour growth in previously irradiated
sites, hereafter referred to as the " tumour bed effect " (TBE), has been repeatedly
observed since its first demonstration by Frankl and Kimball (1914). However,
much of the earlier work on the TBE was done with tumour-host systems compli-
cated by the influence of transplantation immunity. It can be surmised that the
effect of such an irrelevant influence would be greatly to exaggerate the size ofthe
observed TBE.
Merwin, Algire and Kaplan (1950) used the Algire chamber technique to study
under direct microscopic observation the fate ofsmall solidimplants ofan isologous
mouse tumour after transplantation to subcutaneous sites which had received 2000
or 3000 R previously. They concluded that the irradiatedendothelium was rarely
able to produce new vessels. On the other hand, vessels in the implant could
retain function and in one case formed new vessels. Vessels also appeared in local
cellular exudates; these appeared to have grown in from surrounding unirradiated
tissue.
A series of papers by Vermund and his collaborators (Stenstrom et al., 1955;
Vermund, Stenstrom, Mosser and Johnson, 1956; Vermund, Stenstrom, -Mosser
and Loken, 1958; Vermund, 1959; Summers, Clifton and Vermund, 1964) describe
studies ofthe TBE using various strains of mouse tumour injected as tumour pulp.
Tlhese papers represent the most extensive recent examination ofthe phenomenon.
These authors investigated the influence of dose of radiation and of interval
between irradiation and transplantation, and compared the effect on host survival
time of irradiation of tumours in situ and pre-irradiation of the tumour bed.
Among their important observations were demonstrations that no TBE is apparent
for tumours implanted intracerebrally and that host immunity is not necessarily
implicated in the phenomenon. A TBE was displayed using all the tumours they
studied.
Urano (1966), using a mouse sarcoma, studied the influence on the TBE of
variation of dose ofradiation and of interval between irradiation and transplanta-
tion. Tlle potentiality of tumour growth was measured in terms ofgrowth curves
and host survival time.
70
809H. B. HEWITT AND E. R. BLAKE
The present paper describes further investigations of the TBE using two
murine tumours for which other radiobiological data have been reported pre-
viously. It was desired to examine the applicability to these tumours of some of
the principal findings of previous investigators and to extend the enquiry along
lines that are of interest in the context of our current investigations. We have
studied the duration ofthe TBE and its persistence at the site of an excised irradi-
ated tumour, the phase of tumour growth at which the influence operates, the
relation between radiation dose and the magnitude of the TBE, and some other
features of the phenomenon.
MATERIALS AND METHODS
Mice
Mice of both sexes of inbred strain CBA/Ht were used at 2-4 months of age
unless otherwise stated.
Tumowr8
Both solid tumours employed arose spontaneously in the same inbred colony of
mice as was used for the experiments. They were maintained by serial sub-
cutaneous passage in isologous mice. In extensive studies undertaken before and
during the present experiments neither has shown evidence of significant anti-
genicity. The following tumours were used:
(a) C1BA/Ht Sarcoma F.-This is an anaplastic sarcoma which grows with a
volume doubling time of about 2 days. The tumour yields single-cell suspensions
of viable cells on digestion of minced tumour with pancreatic enzymes, and has
been used in radiobiological studies reported previously (Hewitt and Wilson, 1961:
Hewitt, 1966; Baker, Lindop and Hewitt, 1968).
(b) CBA/Ht Sarcoma S.-This sarcoma has been transplanted serially for
several years, during which the volume doubling time has remained at about
10 days, an exceptionally slow rate ofgrowth for a long transplanted tumour. No
success has been had with attempts to produce single-cell suspensions from this
tumour, which was transplanted by the surgical implantation oftumour fragments
of a few mm.3.
(c) CBA/Ht Leukaemias S and R-I.-Of these two strains, S arose spon-
taneously, and R-I was radiation-induced, in mice ofthe substrain which provided
the mice used in the experiments. In each case, transplantation to 50 per cent of
injected mice can be effected with about 2 cells. Neither strain gives rise to
ascites after intraperitoneal injection and both strains produce a final leukaemic
state characterised by gross infiltration of the liver and spleen.
Irradiation
Mice to be irradiated were sedated with 0-125 ml./20 g. body weight ofa 2 5 per
cent solution in saline of tribromoethanol (" Avertin ", Winthrop Laboratories,
N.Y.) injected subcutaneously. They were placed in individual lead boxes from
which one leg was retained out ofthe box up to the groin by sticky tape applied to
the foot. Mice were exposed locally in groups ofeight at a time to 250 kv X-rays
generated at 15 mA and filtered through 0 5 mm. Cu and 1.0 mm. Al. The dose
rate, measured with small condenser ionisation chambers located in the site of a
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leg, was 360 R/min. Except where stated otherwise, a single dose of 2000 R was
delivered to legs of mice breathing air during irradiation. This dose produced
epilation and slight temporary oedema of exposed legs, but no ulceration.
Transplantation of tumours
CBA Sarcoma F was transplanted to the legs of mice using counted single-cell
suspensions prepared by a digestion technique described previously (Hewitt, 1966).
A volume of 0 05 ml. of suspension was injected through a 22-gauge hypodermic
needle into the lowest lateral part of the leg just above the ankle joint. The
number oftumour cells injected was usually 20,000, representing about 1000 times
the number of cells required to give 50 per cent of takes.
CiBA Sarcoma S was transplanted as cubes of a few mm.3 of healthy tumour
inserted subcutaneously into the lower leg laterally through a small transverse
incision which was closed with a metal skin clip.
All experiments were performed aseptically, and the injections and surgical
procedures were all performed under ether anaesthesia.
An experimental group usually comprised 8 mice 4 with the left leg irradiated
and 4 with the right. In most experiments, each animal received a transplant in
the irradiated and unirradiated leg.
MIIasurement of tumour growth
The maximum diameter of each leg was measured with calipers every 1 or
2 days from about the 6th day after transplantation until humane considerations
required killing of the mice. The maximum diameter of normal legs was 4 5-
5*5 mm., and tumour-bearing mice were killed when either tumour attained a
diameter of 15-20 mm. Mean maximum leg diameters in mm. were plotted
against days after transplantation. A straight line could usually be well fitted to
the points by eye. Growth curves for the tumours growing in irradiated and con-
trol legs were plotted together, the TBE being denoted by diversion ofthe curves.
The measurements made did not permit an estimate of tumour mass to be made.
However, their adequacy for comparative purposes was justified by the absence of
any difference oftumour shape on the two sides. In a few experiments, following
the final measurements, tumours were excised and weighed. A 1: 4 ratio ofmean
tumlour weights was obtained when the mean maximum leg diameters were 12 and
16 mm. respectively.
EXPERIMENTS AND RESULTS
(i) The influence of intrinsic tumour growth rate on expression of the TBE
Fig. 1 compares the TBE as demonstrated using the rapidly growing CBA
Sarcoma F (A) and the slowly growing CBA Sarcoma S (B). The ratios of the
slopes of the curves for the control and irradiated legs are 1: 0 6 and 1: 0-42
respectively. Since the range ofgrowth rates covered by these two tumours would
include a high proportion of all murine tumours, it is concluded that intrinsic
tumour growth rate has little or no influence on expression of the TBE. It is of
some interest that the magnitude of the effect is not reduced when the rate of
demand for stroma is reduced.
811H. B. HEWITT AND E. R. BLAKE
(ii) Persistence of the TBE
Six groups each of8 CBA female mice received 2000 R to 1 leg. At intervals of
7, 17, 24, 62, 350 or 450 days after irradiation a group received an injection into
both legs of 20,000 CBA Sarcoma F cells. Growth curves were constructed from
serial measurements ofthe legs in the usual way. In all cases a straight line could
be well fitted to the points by eye. The results of the experiment are shown in
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FIG. 1. Growth of CBA tumours in unirradiated legs (0) and in contralateral legs which
received 2000 R X-rays before transplantation of tumour (0). A rapidly-growing
Sarcoma F; B slowly-growing Sarcoma S.
TABLE I.-The Effect ofLength of Interval between Irradiation and Transplantation
of Tumour Cells on Expression of the TBE
Slope ofleg growth curve
(mm./day)
Interval Control leg Irradiated
(days) (C) leg (R) R/C
7 . 1-5 0-7 . 047
17 . 1-3 0-8 . 0-62
24 . 1-3 0-7 0-54
62 . 1-3 0-7 . 0-54
350 . 0-9 0*9 . 1-00
450 . 1.0 0-5 . 0-50
Table I, in which the slopes ofthe two curves for each group are given in terms of
mm./day. In the final vertical column, the slope ofthe curve for irradiated legs is
given as a fraction ofthe slope ofthe corresponding curve for the unirradiated legs.
The rate ofgrowth of tumour in the control legs for intervals 350 and 450 days is
distinctly less than for shorter intervals. The result of the experiment which
follows (iii) shows that this fall in control tumour growth rate is not due to the
greater age, atthe time oftransplantation, ofthe mice used for the longer intervals.
A review of growth data for Sarcoma F over the period occupied by the present
experiment suggested that there had been a spontaneous alteration of the growth
potential of the tumour within the tumour-host system used.
In all groups except that for an interval of 350 days, the growth rate of irradi-
ated legs was only about half that in the corresponding control legs. The group
for a 350-day interval is distinctive in that the rate of tumour growth in the
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irradiated legs is indistinguishable from that in the control legs. Owing to loss of
mice in the later stages of the experiment, only 5 mice were available for the final
group (450-day interval). In this group, however, the data were augmented by
excising and weighing all tumours after the final leg measurements on the 19th day
after transplantation. The tumours from the control legs weighed 2-0-3.1 g.
(mean 24 g. S.D. 0.38); those from the legs irradiated 450 days previously weighed
0-6-0 9 g. (mean 0-64 g.; S.D. 0.28). Thus, there is substantial evidence from
these results that radiation-induced damage to the subcutaneous tissue which is
sufficient to restrain the growth of tumours transplanted to the irradiated site
persists throughout a large part of a mouse's lifetime.
The failure to demonstrate restraint of growth in the legs irradiated 350 days
previously deserves attention because it is the only failure to demonstrate a TBE in
all the numerous experiments we have done using this tumour and a dose of radia-
tion of 2000 R. It should be added that 16 mice, twice the usual number, contri-
buted the data for this interval.
Owing to the time scale of the experiment, it has not yet been possible to re-
examine the TBE in the region of this interval of time between irradiation and
transplantation, to confirm that the TBE is exerted in two phases separated by an
interval of recovery. Such a bi-phasic effect of irradiation is a well-known pheno-
meiinon in clinical radiotherapy, where earlier and later effects of radiation on the
normal tissues represent entities of different pathology.
(iii) The effect of age of host on expression of the TBE
The conditioins of the last experiment (ii) involved a wide difference in the ages
of the mice of different groups at the time tumour cells were injected. It was.
therefore, desirable to ensure that the TBE is equally expressed in relatively young
aind old mice. In Fig. 2 are shown the growth curves for control and irradiated
legs using female CBA mice of age groups 96-117 days and 390-635 days. The
comparison was made in a single experiment in which the interval between irradia-
tionl and transplantation was 20 days. The figure shows that the TBE is equally
expressed in mice of the two age groups and that host age has not influenced the
rate of growth of the tumours in either control or irradiated legs. It is concluded
that the results of the last experiment were not complicated by differences of the
age of the mice at the time of transplantation.
(iv) Phase of tumour growth during which TBE influences growth
It has been observed that in all cases where mean maximum leg diameter
growth curves for control and irradiated legs have been charted together the two
linear curves intersect at a point corresponding to the maximum diameter of the
normal mouse leg (about 5 mm.). That is, measurable enlargement of the legs
occurs at about the same time on the two sides; the latent periods of growth
appear to be similar. In the case of tumours grown from relatively small inocula
oftumour cells and in which a latent period of 6-8 days is observed before measur-
able growth is apparent, the absence of a difference of latent period for tumours
grown in the control and irradiated legs implies that no relative restriction of
growth occurs in the irradiated legs during this early phase of growth. The
following experiment was designed to enhance the opportunity of detecting a
difference of latent period for tumours growing in control and irradiated sites.
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Three groups of 8 male CBA mice received 2000 R to one leg. Thirteen days
after irradiation, mice of the three groups received in both legs an injection of
78,000, 10,000, or 1300 cells of CBA Sarcoma F. Maximum leg diameters were
measured at intervals after injection of tumour cells, and growth curves were
plotted in the usual way. Fig. 3 shows that the TBE was equally apparent in all
three pairs of curves. In all groups, the linear growth curves for control and
irradiated legs intersect at a point corresponding to a normal leg diameter ofabout
5 mm. on the ordinate. As expected, the point of intersection is displaced pro-
gressively to the right as the size of the inoculum is reduced. Even with the
lowest cell dose used, however, the latent period of tumours on the irradiated side
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FIc. 2.-Growth of Sarcoma F in unirradiated (A) and pre-irradiated (A) legs of young mice,
and in unirradiated (0) and pre-irradiated (e) legs of old mice. Exposure dose of irradlia-
tion, 2000 R. Time between irradiation and tumour transplantation, 20 days.
cannot be distinguished from that of tumours on the control side. If the relative
restriction of growth in the irradiated leg, as seen during the measurable phase of
growth, were being exerted during the occult phase ofgrowth, a difference oflatent
period should be observed for tumours growing on the two sides, and this difference
should increase as the size ofthe inoculum is reduced. The evidence provided bv
this experiment strongly suggests that restraint oftumour growth in an irradiated
site is not exerted until the tumour approaches a size of at least 1 mm.3. This
finding is not unexpected when it is appreciated that microtumours can obtain
their nutritional requirements by diffusion from existing normal vessels, and would
suffer relative nutritional deprivation only when they attained a size requiring their
vascularisation. The incapacity of the irradiated site to provide new stroma b\
the proliferation ofresident endothelial elements would only become apparent after
the demand is made.
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(v) The TBE in relation to leukaemia
The TBE was sought in two separate experiments using different leukaemia
strains. In each experiment, a constant inoculum of leukaemia cells was injected
into the irradiated legs of 8 mice and into the unirradiated legs of an equivalent
group. None of the injected mice developed a tumour at the site of injection
before the animals became moribund with the generalised disease. In the case of
both leukaemia strains, there was no significant difference in mean latent periods
before development of generalised disease in the two groups of mice compared.
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FIG. 3. Growth of Sarcoma F in unirradiated (0) and contralateral irradiated (0) legs.
Effect of varying size of inoculum of tumour cells. Exposure dose of irradiation, 2000 R;
interval between irradiation and transplantation, 13 days.
Since no local tumour is formed before dissemination ofthe disease, the injected
cells evidently migrate to the viscera along existing tissue spaces, lymphatics or
blood vessels. No stroma is called for, and therefore no delay is to be expected in
the development of the generalised disease after injection into irradiated sites.
(vi) The effect of dose of irradiation on the magnitude of the TBE
The standard single dose of irradiation used in most of the experiments in this
investigation ofthe TBE is 2000 R. This dose was found to be sufficient forregular
demonstration of the TBE yet below the necrotising dose for mouse skin.
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In the experiment to be described here the magnitude ofthe TBE was investi-
gated using single doses of radiation between 100 R and 4000 R. Six groups of
male CBA mice received the specified dose of irradiation to one leg. Twelve days
after irradiation both legs ofall mice were injected subcutaneously in the usual site
with 30,000 cells of CBA Sarcoma F. Maximum leg diameters were measured at
intervals from the 6th day after transplantation. The doses ofradiation used were
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Fig. 4.-Growth of CBA Sarcoma F in unirradiated legs (0) and in contralateral legs which
had been exposed to various doses of irradiation (40) 12 days before transplantation of
tumour cells.
100 500 1000, 1500 2000 and 4000 R. The number of mice per group was 6-8,
except for the group exposed to 1000 R, in which only 4 mice were available for
study. Fig. 4 shows the comparative growth curves for irradiated and control legs
following the doses of radiation used. With doses of 100 and 500 R no difference
between the growth rates in the control and irradiated legs is apparent. Doses of
1000 R and above all resulted in relatively slower growth in the irradiated legs.
The growth curves obtained by plotting mean maximum leg diameters against
time for this experiment were not always linear. In Table II, therefore, the slopes
of the curves, expressed in mm./day, have been taken from the principal, butTRANSPLANTED TUMOURS IN PRE-IRRADIATED SITES
TABLE II. The Effect of Dose ofPre-irradiation on Expression of the TBE
Slope of leg growth curve
(mm./day)
Dose of Control leg Irradiated
radiation (R) (C) leg (R) R/C
100 1-2 1.1 0-92
500 1-1 1-1 1-00
1000 0 9 0 6 0-67
1500 1-1 0-6 0-55
2000 1*1 0 7 0 64
4000 1*4 0 7 050
limited, part of the curves between 8 and 13 mm. After doses of 100 and 500 R.
the fraction R/C is close to l0. A significant reduction ofthe fraction below 10 is
seen for doses of 1000 R and above. However, there is no useful discrimination of
the effect of dose over the range 1000 to 4000 R.
A dose of 4000 R to the leg of a mouse results in wet desquamation and con-
siderable oedema of the foot, with some disturbance of the health and mobility of
the animals. The unusual distortion of the early parts of the growth curves for
tumours growing in the two sides of the mice which received 4000 R, as shown in
Fig. 4, probably reflects these local and constitutional complications. The
exceptionally high rate of growth of the tumours in the unirradiated legs of the
4000 R group after the 9th day may be related to the relatively low rate ofgrowth
of these control tumours up to that time.
The results of this experiment display a further feature of interest concerning
the terminal part of the growth curves. It will be seen in Fig. 4 that, where the
dose of radiation is insufficient to cause restraint of growth in the irradiated leg
relative to that in the contralateral control leg (100 and 500 R), both curves show a
terminial reduction of growth rate. No such terminal slowing is seen after doses
which do restrain growth in the irradiated leg. This observation is understandable
w-hen it is appreciated that the taxing of the host's constitutional resources must
depend on the sum of the tumour masses on the two sides. With both tumours
growing at about equal control rates, as in the 100 and 500 R groups, severe taxing
of host resources would occur earlier in time than in the cases where growth of one
ofthe tumours is restricted. The severity ofthe taxing ofthe host constitution is
shown by the finding that nine mice examined on the final day of measurement had
blood haemoglobin values which were between 29 and 35 per cent of normal.
The possibility cannot be excluded that there is some interaction of a competi-
tive character between the two tumours during the course of their growth in the
host. Such interaction may serve to accentuate the difference in tumour growth
onl the two sides by which the TBE is demonstrated in the experimental design
used here.
(vii) An attempt to modify the latent damage to the tissues which is responsible for the
TBE
The results of Experiment (ii), in which it was shown that the TBE was
demonstrable in a site irradiated as long as 15 months before the transplantation of
tumour cells, suggests that the relevant damage done by the irradiation is stored in
cells with a very low rate ofturnover. The effect ofa local transplant is evidently
to stimulate division in the damaged cells, so that the latent damage is expressed;
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the attempt ofthe tissue to provide stroma is thus frustrated as soon as the demand
is made; and this frustration of stromal provision would continue as long as the
growing tumour extended further into previously irradiated tissue. The effect of
irradiation on the stroma of an established, growing tumour might be expected to
entail certain differences from the effect on quiescent tissue, in so much as the
tumour stroma, and the normal tissue immediately adjacent to the tumour edge,
are presumed to be in a state of proliferation at the time of irradiation. In this
case, the damage should be expressed promptly and be repaired by the proliferation
of intact surviving cells. It is possible that such a difference in the rate ofexpres-
sion and repair ofnormal tissue damage between pre-irradiation ofthe tumour bed
and irradiation of an established tumour may explain a fact already referred to in
the introduction. This is, that irradiated tumours frequently regain, after tem-
porary regression, the exponential rate ofgrowth they exhibited before irradiation,
whereas tumours transplanted to pre-irradiated beds show continued retardation
of growth.
The experiment to be described here was designed to test the above interpreta-
tion of the TBE. It was conceived that if a well-established tumour were to be
irradiated in vivo with the usual dose of irradiation used to demonstrate the TBE
(2000 R) the damage done to the stromal and adjacent normal tissues would be
expressed andrepaired. The tumour could then be excised and the surgical wound
permitted to heal. A second tumour transplanted to the same site some days later
should fail to show restraint ofgrowth if the greater part ofthe radiation damage
has been repaired. Ifit has not been repaired, the growth restraint associated with
the TBE should still be apparent. It was convenient to use CBA Sarcoma S for the
first transplant and CBA Sarcoma F for the second transplant. Sarcoma S is rela-
tively quite slow in growth; it forms a more or less spherical tumour without
infiltration of the surrounding tissue and is easily excised; if there were any grow-
ing remnant of Sarcoma S left behind after excision, its relatively slow rate of
growth would ensure that it made no significant contribution to the measured
growth ofthe secondary transplant ofthe much more rapidly growing Sarcoma F.
The procedures required for this experiment did not permit use of the two legs
of a mouse for comparative purposes. A separate group of mice was used for each
set ofexperimental conditions and only one leg was used. Four groups of 10 male
CBA mice received the sequence and distribution oftreatments shown in Table III.
TABLE III.-Sequence and Distribution ofProcedures Used to Investigate
Persistence of the TBE at the Site of Excision of an Irradiated Tumour
Group
Day Procedure A B C D
0 Implant of Sarcoma S + A - -
52 Irradiation of leg (2000 R) + +
57 . Excision of Sarcoma S + + --
65 Implantation Sarcoma F . + t + +
At the time ofirradiation, on the 52nd day, mice ofgroups A and B had discrete
Sarcoma S tumours of 8-10 mm. diameter growing in the legs.
The mean weights ofthe tumours excised on the 57th day from mice ofGroups
A and B were 460 and 850 mg. respectively.
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Eight days after the excision of tumours from mice of Groups A and B, by
which time the surgical wounds were healed, the legs of mice of all groups received
an injection of 20,000 cells of Sarcoma F.
From the 6th day after injection ofSarcoma F cells, the maximum leg diameters
were measured at intervals. The growth curves for each group are represented
graphically in the usual way in Fig. 5. To avoid confusion, the experimental
points have been omitted; none departed by more than 0-5 mm. from the cursve to
which it contributed.
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FIG. 5. Growth of Sarcoma F in the legs of mice which had received the various pre-treatments
denoted in Table III.
It will be appreciated that the curves for Groups C and D represent a simple
demonstration ofthe TBE using Sarcoma F alone. However, the discrimination of
the curve for growth in irradiated legs (C) from that for growth in unirradiated legs
(D) is very poor compared with previous results using contralateral legs. This
poorer discrimination may well be due to the different experimental conditions.
The possibility that demonstration of the TBE is accentuated under conditions
where the tumours compared are carried in the same animal has already been
referred to.
The identity of the curves for Groups B and D indicates that previous growth
and excision of a tumour in the site to which cells of Sarcoma F are transplanted
has no measurable influence on growth of Sarcoma F.
Comparison of the curve for Group A with that for Group B provides the
essential information sought from the experiment. It is evident from the diversion
ofthese curves that growth ofSarcoma F is restrained in a site which was irradiated
during residence ofa previous tumour. The TBE was, in fact, as pronounced as in
the control situation, in which the quiescent normal tissue was irradiated. Thus,
the experiment failed to support the hypothesis outlined at the beginning of this
section, an implication ofwhich is that the TBE is rapidly repaired when the radia-
tion is given to tissue under stimulation by a growing tumour.
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DISCUSSION
In previous studies of the TBE by other authors, the effect has often been
demonstrated by comparing the survival times of the control and pre-irradiated
mice. We have avoided this measure of the effect in the interests of animal
welfare. Nevertheless, it appears to us that prolongation of the survival of
animals to a stage at which they are in extremis extends the enquiry in a way that
adds undesired complications. Even those animals which we have sacrificed
before humane considerations have demanded it have been found to have blood
haemoglobin concentrations of less than 30 per cent of normal. Such severe
dilapidation of host resources inevitably exerts a secondary influence on tumour
growth, so that the measurement of survival takes account of host changes which
are not strictly relevant to the enquiry.
Growth curves constructed from measurements ofmean maximum leg diameter
appear to provide for a sufficient demonstration of the TBE. Data given for
Experiment (ii) indicate that a difference of mean maximum leg diameter of only
4 mm. signifies as much as a 4-fold difference of mean tumour mass between the
groups compared.
The results ofExperiment (ii), in which the duration ofthe TBE was examined,
conforms to the finding of Summers et al. (1964) that the effect remains un-
diminished for 254 days, and to that ofUrano (1966) that it was undiminished after
84 days. Our own studies with CBA Sarcoma F have extended the interval to
450 days. Summers et al. (1964) pointed out that the mechanism underlying the
TBE may not be the same at different intervals after irradiation. Our failure to
demonstrate the effect after an interval of 350 days in an experiment using 16 mice,
and its return by 450 days, suggests that the TBE could be a biphasic effect, with
recovery between the two phases. Late sclerotic changes seen in irradiated hypo-
dermic tissue appear from histological studies to have a pathology distinct from
that ofearlier damage (Lacassagne and Gricouroff, 1958) and it is possible that the
biphasic exertion of the TBE suggested by our results is a functional consequence
of these distinguishable histological states.
The results of Experiment (iv) suggest that there is no restraint of tumour
growth resulting from pre-irradiation until the tumour size is sufficient to produce
measurable enlargement of the legs. It is estimated that the critical size may be
only a few cubic millimeters. Up to this size, it is probable that the tumours
receive their requirements by diffusion from existing vessels, which should retain
their integrity until a demand for their proliferation is made. Deficiencies would
arise only when the latent damage is expressed in response to a stimulus to cell
division. The conversion oflatent to manifest radiation damage by application of
a stimulus to proliferation has been demonstrated in many tissues whose normal
cells display a low rate of cell turnover. Irradiated liver exhibits damage only
after partial hepatectomy (Weinbren, Fitschen and Cohen, 1960); irradiated
thyroid, after the administration of goitrogens (Philp, Crooks, Macgregor and
McIntosh, 1966); and irradiated peripheral nerves, after nerve section (Cavanagh,
1968).
The result of Experiment (vi) in which the dose dependence of the TBE was
examined, shows that there is a threshold up to some dose between 500 and 1000 R.
Summers et al. (1964) also found no significant TBE with doses of 500 R or less.
We have found no difference in the magnitude of the TBE over the dose range
820TRANSPLANTED TUMOURS IN PRE-IRRADIATED SITES
1500 to 4000 R. This poor discrimination of dose limits the scope of more detailed
studies of the dose-effect relationship, such as those involving fractionation.
Using mouse survival time for demonstration of the TBE, Urano (1966) found no
increase of effect over the range 2000 to 4000 R; using measurements of tumour
growth, the effect was maximised at 3000 R. Summers et al. (1964) Ifound
plateauing of the effect at 2000 R with one tumour and at 3000 R with another.
Considerable difficulties are encountered when we attempt to explain the TBE
in terms of quantitative cellular radiobiology as applied to the host cell populations
(probably fibroblasts and endothelial cells) which provide the stroma ofthe tumour.
Several explanations can be suggested for the possible existence of a threshold.
Thetwo features which are difficult to accommodate in such formulation ofthe effect
are: firstly, the plateauing of the effect with increasing dose; and secondly, the
failure entirely to suppress measurable tumour growth using a dose as high as
4000 R. Both these findings imply that a certain rate of tumour growth can be
attained which is independent of the proliferative capacity of the locally available
cells responsible for the contribution of new stroma. A dose of 4000 R to the
tumour bed, which still permits a substantial rate oftumour growth, would destroy
the reproductive capacity ofa population ofwell-oxygenated cells very much larger
than could be accommodated in the entire exposed limb. Assuming that the
radiosensitivity of the relevant cells is similar to that of other cells of the species
which have been directly measured, a quite large fraction ofthe cells would have to
be hypoxic if a small number ofthe cells were to retain their capacity for indefinite
proliferation. A relatively high proportion ofhypoxic cells in the normal tissue of
an animal breathing air would be unusual. In any case, the existence of such a
protected subpopulation of cells would not explain the plateauing of the effect
found by all investigators who have provided data suitable for its demonstration.
Several further theoretical explanations for the failure of large doses of radiation
to suppress tumour growth can be considered. Firstly, there is the possibility that
tumour cells can infiltrate adjacent normal tissue, with deployment of the cells
among existing intact vessels, a mode ofgrowth exhibited by leukaemia cells in the
livers ofleukaemic mice. However, the capacity to infiltrate without also evoking
stroma appears to be peculiar to leukaemia cells. As shown in Experiment (iv) of
our results, leukaemia cells fail to form tumours in the subcutaneous tissue.
Sarcoma F, on the other hand, would be expected to stimulate proliferation of
endothelial cells, in which event latent damage would be expressed and no surviving
cells would be available for repair of the damage. A second mechanism for ensur-
ing provision of stroma in a heavily irradiated site would be the importation by
migration of suitable intact cells from the nearest unirradiated tissues. However,
in the present experiments the tumour cells are deposited well within the irradiated
volume and would be separated from unirradiated tissue above the groin by a coIn-
siderable depth of irradiated tissue, whose damage would be expected to remain
latent. Inthese circumstances thenearest unirradiated tissuewould notbeexposed
to a local stimulus to proliferation until tumour growth is well advanced.
In view of the limitations of these possible mechanisms for the derivation of
tumour requiremenits from heavily irradiated normal tissue, consideration may be
given to a process of more questionable status: the admission to the irradiated zone
of cells of angioblastic potentiality derived from the circulating blood. It is
generally considered that, in the adult, all new vascular tissue is formed by pro-
liferation of existing endothelial tissue (Le Gros Clark, 1945). Embryological
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texts favour very early restriction of angioblastic potentiality to the cells of the
vitelline plexus, the vascular system of the embryo being formed by direct exten-
sions ofthis primordialtissue. However, the unique character ofthe tissue damage
done by irradiation may very well evoke processes which are not required for the
repair of other forms of damage. The exertion of angioblastic potentiality by
cells derived from the peripheral blood and accumulated in exudates could provide
for modified, and possibly inferior, vascularisation of tumours growing in ir-
radiated tissue. It is to be noted that the efficiency of such a postulated process
would be unrelated to the dose ofpre-irradiation, since the cells responsible would
be recruited from an unirradiated cell population. The activation oflatent angio-
blastic potentiality in a class of circulating leucocyte certainly conflicts with pre-
vailing views concerning the origin of new vessels in the mature animal (see
Cameron, 1952, for a review of this topic), and much more sophisticated evidence
would be required for more serious consideration ofthe concept. It is examined in
the present context only in an attempt to explain extensive growth of tumours in
sites which have received a dose of radiation sufficiently large to abolish the pro-
liferative capacity ofall well-oxygenated endothelial cells in the irradiated volume.
There is no reason to believe that the TBE would not be manifested in Man;
but there is only one circumstance in radiotherapy in which the conditions would
strictly simulate those contrived in the experiments. Thiswould be the arrival ofa
malignant cell embolus in a tissue which had received " prophylactic " irradiation.
If a TBE were present in such a situation, the time taken for the tumour volume to
increase from a few cubic millimetres to a clinicallydetectable size might bedoubled.
For volume doubling times ofthe order ofthose displayed by clinical tumours, this
would represent a substantial delay in the appearance of the metastasis compared
with similar embolic metastases to an unirradiated site.
Dr. H. S. Reinhold (1968, personal communication) has found that pre-
irradiation of the subcutaneous sites in which measured inocula ofrat tumour cells
are injected does not increase the number of cells required for successful transplan-
tation, although the latent period before detection of the tumours is increased.
This finding conforms to the conclusion made from Experiment (iv) ofthis paper
that pre-irradiation has no influence on the initial stage of tumour growth.
Observation of an increase in latent period for tumours growing in irradiated
sites would depend upon the mean tumour size at the time they are first detected.
The design of the experiments undertaken here is such that the first indication of
tumour growth involves some interpolation from the overall growth curve and
represents very early detection. Where detection requires the formation of a
readily palpable tumour, an increase in latent period would certainly be observed
in our experimental system.
The fact that irradiated tumours frequently regain the exponential rate of
growth they displayed before irradiation, anddo not commonlydisplaytherestraint
of growth regularly observed in a pre-irradiated site, still requires elucidation.
The results of Experiment (vii) provided no support for the hypothesis adduced in
that section, and we are unable to conceive an alternative. The recurrence times
of clinical tumours after irradiation with doses giving a high cure rate, are shorter
than we should expect for small surviving cell populations growing exponentially
with volume doubling times ofthe order ofthose commonly encountered in clinical
tumours (Suit, Wette and Lindberg, 1967; Porter, E. H., 1967, personal communi-
cation). Thus, consideration of a TBE does not appear to be required for the
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interpretation of clinical tumour response. A similar conclusion has been reached
concerning the response ofsome experimental tumours to single doses ofirradiation
(Hewitt, 1967).
A general conclusion from the results ofexperiments on the TBE is that whilst
these studies pose interesting problems of interpretation in terms of quantitative
mammalian cellradiobiology, theyprovide no evidence to support an assertion that
" indirect " effects ofradiation on the stroma oftumours are ofimportance to their
radiotherapeutic eradication.
SUMMARY
1. The volume growth rate of both a rapidly-growing and a slowly-growing
murine sarcoma was measurably reduced in the subcutaneous tissue of mouse legs
which had been previously exposed to a single dose of 2000 R 250 kv X-rays, com-
pared with the rate in the contralateral unirradiated legs.
2. Growth restraint was similar in legs irradiated 7, 17, 26 and 62 days before
the injection of tumour cells. No restraint was observed with an interval of 350
days, butrestraint was again apparent whenthe interval was extendedto 450days.
The possibility ofabi-phasicexertionoftheeffectofpre-irradiationwasentertained.
3. The growth restraining effect ofpre-irradiation was exerted equally in mice
aged 3-4 months and mice aged 12-21 months.
4. Evidence was provided which strongly suggested that pre-irradiation ofthe
site ofinjection oftumour cells had no influence on the latent phase ofsubsequent
tumour growth. This limitation of the effect to later phases of growth was con-
sidered to be associated with an ability ofmicrotumours to grow independently of
vascularisation.
5. The subcutaneous injection oftwo strains of murine leukaemia cells did not
give rise to a local tumour in pre-irradiated or normal control sites. The latent
period before the development ofgeneralised leukaemia was similar after injection
into irradiated and control sites.
6. No restraint oftumour growth was detected in sites pre-irradiated to a dose
of 100 or 500 R. The minimum effective dose was between 500 and 1000 R, and
there was no measurable discrimination of the effect of dose in the range 1000 to
4000 R.
7. The growth restraining effect of pre-irradiation was fully manifested when
the radiation had been delivered to a previous tumour resident in the same site and
subsequently excised.
The results are discussed in relation to quantitative cellular radiobiology and
the volume response of tumours to irradiation.
We are indebted to Miss Angela Walder for her outstanding management ofthe
breeding and care ofthe animals used. The expenses ofthe research were wholly
defrayed by the British Empire Cancer Campaign for Research, whose support we
gratefully acknowledge.
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